Case number 1:21-cv-01766
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 14, 2023 | 24 | CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 2/14/2023. (nmf) (Entered: 02/14/2023) (6) |
| Feb 14, 2023 | 23 | PROPOSED CONSENT JUDGMENT Between Boehringer and Mankind and LifeStar Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 02/14/2023) (6) |
| May 2, 2022 | 22 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by James G. Gorman, III on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Gorman, James) |
| Apr 19, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-01485-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1485-CFC ONLY. (nmf) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Civil Action Nos. 21-1485, 21-1486, 21-1487, 21-1573, 21-1766 and 22-220 are consolidated for all purposes. All future filings shall be made in Lead Case No. 21-1485-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. Associated Cases: 1:21-cv-01485-CFC et al.(nmf) |
| Apr 13, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Apr 7, 2022 | 21 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd) |
| Apr 5, 2022 | 20 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Anna Elizabeth Currier on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Currier, Anna) |
| Apr 5, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Apr 1, 2022 | 19 | Order (4) Docket Text: ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 17, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the 3/15/2022 Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter has been replaced with a corrected version in order to to correct an error in the table on page 2 with respect to the answer date for defendant Laurus in the 22-220 action per request of filer. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 15, 2022 | 18 | Letter (4) Docket Text: Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter - re (25 in 1:21-cv-00530-CFC) Letter. (Dellinger, Megan) (Main Document 18 replaced on 3/17/2022) (nmf, ). |
| Mar 15, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jay P. Lessler, Dipu A. Doshi, Serena S. Gopal for Lifestar Pharma LLC, Mankind Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Mar 14, 2022 | 17 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Serena S. Gopal - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Mar 14, 2022 | 16 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lessler - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Mar 14, 2022 | 15 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dipu A. Doshi - filed by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, MOTIONS for Pro Hac Vice Appearance of Attorneys re [16] Jay P. Lessler, [15] Dipu A. Doshi, [17] Serena S. Gopal, filed by Lifestar Pharma LLC, Mankind Pharma Ltd. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 11, 2022 | 14 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding case management issues. (Phillips, John) |
| Mar 8, 2022 | 13 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding coordinated discovery and Markman - re (11 in 1:21-cv-01487-CFC, 11 in 1:21-cv-01487-CFC, 19 in 1:21-cv-00530-CFC, 19 in 1:21-cv-00530-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01486-CFC, 11 in 1:21-cv-01486-CFC, 13 in 1:21-cv-01485-CFC, 13 in 1:21-cv-01485-CFC) Order,, Set Deadlines,. (Dellinger, Megan) |
| Mar 4, 2022 | 12 | Mankind's Corporate Disclosure Statement (2) |
| Mar 4, 2022 | 12 | Lifestar's Corporate Disclosure Statement (2) |
| Mar 4, 2022 | 12 | Exhibit A (80) |
| Mar 4, 2022 | 12 | Main Document (25) Docket Text: ANSWER to [1] Complaint, // Defendants' Answer and Affirmative Defenses to Complaint and Counterclaims, COUNTERCLAIM against All Plaintiffs by Mankind Pharma Ltd., Lifestar Pharma LLC. (Attachments: # (1) Exhibit A, # (2) Lifestar's Corporate Disclosure Statement, # (3) Mankind's Corporate Disclosure Statement)(Orlacchio, Adam) |
| Feb 8, 2022 | 11 | Order (4) Docket Text: ORDER: IT IS ORDERED that, on or before March 8, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/8/2022.) Signed by Judge Colm F. Connolly on 2/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Jan 18, 2022 | 10 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to March 4, 2022 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jan 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to March 4, 2022, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Reset Answer Deadlines: Lifestar Pharma LLC answer due 3/4/2022; Mankind Pharma Ltd. answer due 3/4/2022. Ordered by Judge Colm F. Connolly on 1/18/2022. (kmd) |
| Jan 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to January 18, 2022, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Reset Answer Deadlines: Lifestar Pharma LLC answer due 1/18/2022; Mankind Pharma Ltd. answer due 1/18/2022. Ordered by Judge Colm F. Connolly on 1/6/2022. (kmd) |
| Jan 5, 2022 | 9 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to January 18, 2022 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Dec 22, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Dec 21, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Lifestar Pharma LLC served on 12/20/2021, answer due 1/10/2022. (Egan, Brian) |
| Dec 21, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Mankind Pharma Ltd. served on 12/20/2021, answer due 1/10/2022. (Egan, Brian) |
| Dec 17, 2021 | 6 | Summons Issued (2) |
| Dec 17, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lifestar Pharma LLC on 12/17/2021; Mankind Pharma Ltd. on 12/17/2021. (Attachments: # (1) Summons Issued)(mal) |
| Dec 16, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. No for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (mal) |
| Dec 16, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (mal) |
| Dec 16, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/11/2021. Date of Expiration of Patent: 04/03/2034. 30 Month Stay Deadline: Not Applicable. (mal) |
| Dec 16, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Dec 16, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 16, 2021 | 1 | Complaint* (1) |
| Dec 16, 2021 | 1 | Exhibit A (52) |
| Dec 16, 2021 | 1 | Main Document (9) Docket Text: COMPLAINT filed with Jury Demand against Lifestar Pharma LLC, Mankind Pharma Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3765412.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(mal) |
